7:27 PM
 | 
Oct 23, 2008
 |  BC Extra  |  Company News

sanofi-aventis withdrawing Acomplia

sanofi-aventis (Euronext:SAN; NYSE:SNY) is withdrawing obesity drug Acomplia rimonabant after EMEA's CHMP recommended the suspension of its marketing authorization. CHMP said "new data from post-marketing experience and ongoing...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >